Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A mechanistic computational model of checkpoint-inhibitor combinations in mice that predicts synergy but lacks experimental validation of the proposed mechanisms in humans and does not address clinical efficacy or safety.
This is a narrative review synthesizing preclinical and early-stage evidence for mRNA malaria vaccines; it raises the prospect of mRNA platforms as superior to existing vaccines but does not report clinical trial data, efficacy estimates, or head-to-head comparisons in humans.
This is a narrative review that raises questions and summarizes progress rather than reporting empirical results with effect sizes or comparative outcomes to answer them.
Therapeutic Advances in Vaccines and Immunotherapy
A narrative review synthesizing current melanoma vaccine strategies, technologies, and clinical trial landscape without presenting original experimental data or meta-analysis of outcomes.
This is a narrative review or commentary describing the concept and theoretical promise of tolerogenic vaccines without reporting original experimental data, efficacy results, or clinical outcomes.
An expert interview on vaccine design principles and adjuvant strategy; informative for research direction but not empirical evidence of clinical efficacy or safety.
A critical narrative review synthesizing evidence across AI-genomics applications for infectious disease surveillance, identifying methodological gaps and recommending governance priorities rather than reporting new empirical results.
A narrative review synthesizing current evidence on personalized cancer vaccine development, proposing a framework for future optimization rather than reporting original empirical findings.